IFNA1 and experimental autoimmune encephalomyelitis: Similarly, in experimental autoimmune encephalomyelitis models, supplementation with Trp or Trp-derived AhR agonists enhanced IFN suppression and limit central nervous system (CNS) inflammation in an AhR-dependent mechanisms (Rothhammer et al., 2016).